Literature DB >> 17435628

Case 15: when a stroke is not a stroke.

W Bryan Burnette1.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17435628      PMCID: PMC1924978     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


× No keyword cloud information.
  45 in total

1.  The biology of JC virus and progressive multifocal leukoencephalopathy. Proceedings of a workshop.

Authors: 
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.

Authors:  M D Geschwind; R I Skolasky; W S Royal; J C McArthur
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

3.  Progressive multifocal leucoencephalopathy isolated to the posterior fossa in a patient with systemic lupus erythematosus.

Authors:  R P White; S Abraham; S Singhal; H Manji; C R A Clarke
Journal:  Rheumatology (Oxford)       Date:  2002-07       Impact factor: 7.580

4.  Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

Authors:  Igor J Koralnik; Renaud A Du Pasquier; Marcelo J Kuroda; Jörn E Schmitz; Xin Dang; Yue Zheng; Michelle Lifton; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.

Authors:  Amar Safdar; Ronald J Rubocki; Joseph A Horvath; Kailash K Narayan; Robert L Waldron
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

6.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  A De Luca; M L Giancola; A Ammassari; S Grisetti; M G Paglia; M Gentile; A Cingolani; R Murri; G Liuzzi; A D Monforte; A Antinori
Journal:  J Infect Dis       Date:  2000-08-31       Impact factor: 5.226

Review 8.  Immune response in progressive multifocal leukoencephalopathy: an overview.

Authors:  T Weber; F Weber; H Petry; W Lüke
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

9.  Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

Authors:  A Antinori; A Ammassari; M L Giancola; A Cingolani; S Grisetti; R Murri; L Alba; B Ciancio; F Soldani; D Larussa; G Ippolito; A De Luca
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

10.  A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

Authors:  Christina M Marra; Natasa Rajicic; David E Barker; Bruce A Cohen; David Clifford; M Judith Donovan Post; Armando Ruiz; Brian C Bowen; Meei-Li Huang; Jennie Queen-Baker; Janet Andersen; Sue Kelly; Sharon Shriver
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.